Investors may find better options in Western Midstream Partners and Encompass Health

From Nasdaq: 2024-09-08 22:22:20

Investors who have seen growth in Visa stock may want to consider Western Midstream Partners and Encompass Health as more attractive options. Both companies have shown higher revenue and profit growth in the last twelve months and are trading cheaper than Visa. Additionally, Trefis High Quality Portfolio has outperformed the S&P 500 in 2023 by shifting to these stocks.

Western Midstream Partners offers higher revenue growth, operating profit growth, and a better margin trend than Visa. Encompass Health has also outperformed Visa in terms of market returns over the past 6 and 12 months. Despite Visa’s higher valuation, both WES and EHC are showing stronger growth and potential market rewards.

Western Midstream Partners operates in a lucrative sector with steady cash flows from long-term contracts. The company benefits from trends like increased demand for electricity from electric vehicles and AI. Encompass Health, a leader in post-acute care, serves a growing population in need of specialized recovery services. Both companies offer investors strong growth potential.

Trefis’ market-beating portfolios, including HQ with downside protection, provide insight into potential high-quality investment options. Visa’s lower growth and higher valuation compared to Western Midstream Partners and Encompass Health suggest that these companies may offer better returns in the future. Investors should consider shifting allocation to more attractive stocks for potential long-term gains.



Read more at Nasdaq: Swipe Left On Visa Stock, Pick These Alternatives?